|
|
||||||||
Incubation of 125I-labelled insulin-like growth factor-I (IGF-I) with rat plasma at 4 °C led to the transfer of approximately half the radioactivity to 150 kDa and smaller complexes with IGF-binding proteins. The extent of association was greater with labelled IGF-II and essentially absent with the truncated IGF-I analogue, des(1–3)IGF-I. A greater degree of binding of IGF peptides with binding proteins occurred after i.v. injection of the tracers into rats, but most of the des(1–3)IGF-I radioactivity remained free. Measurement of the total plasma clearances showed the rapid removal of des(1–3)IGF-I compared with IGF-I and IGF-II; the mean clearances were 4·59, 1·20 and 1·34 ml/min per kg respectively. The mean steadystate volume of distribution was larger for des(1–3)IGF-I than for IGF-I and IGF-II (461, 167 and 181 ml/kg respectively), probably because of the differences in plasma protein binding. With all tracers, radioactivity appeared in the kidneys to a greater extent than in other organs. The amount of radioactivity found in the adrenals, brain, skin, stomach, duodenum, ileum plus jejunum and colon was in rank order, des(1–3)IGF-I > IGF-I > IGF-II. Since this ranking is the opposite of the abilities of the three IGF peptides to form complexes with plasma binding proteins, we propose that the plasma binding proteins inhibit the transfer of the growth factors to their tissue sites of action. Moreover, we suggest that IGF analogues that are cleared rapidly from blood may have greater biological potencies in vivo.
Journal of Endocrinology (1991) 128, 197–204
This article has been cited by other articles:
![]() |
M D Ashworth, J W Ross, D R Stein, D T Allen, L J Spicer, and R D Geisert Endocrine disruption of uterine insulin-like growth factor expression in the pregnant gilt Reproduction, October 1, 2005; 130(4): 545 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. F. Lu, X. G. Jiang, Y. B. Lu, J. H. Bai, and Z. B. Mao Characterization of a Novel Positive Transcription Regulatory Element That Differentially Regulates the Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Gene in Senescent Cells J. Biol. Chem., June 17, 2005; 280(24): 22606 - 22615. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, G. Tortolero-Luna, H. Zhao, D. Phatak, M. R. Spitz, and M. Follen Serum Levels of Insulin-like Growth Factor I and Risk of Squamous Intraepithelial Lesions of the Cervix Clin. Cancer Res., August 1, 2003; 9(9): 3356 - 3361. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Spoerri, S. Caballero, S. H. Wilson, L. C. Shaw, and M. B. Grant Expression of IGFBP-3 by Human Retinal Endothelial Cell Cultures: IGFBP-3 Involvement in Growth Inhibition and Apoptosis Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 365 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gregorevic, D. R. Plant, K. S. Leeding, L. A. Bach, and G. S. Lynch Improved Contractile Function of the mdx Dystrophic Mouse Diaphragm Muscle after Insulin-Like Growth Factor-I Administration Am. J. Pathol., December 1, 2002; 161(6): 2263 - 2272. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Shoubridge, C.-B. Steeb, and L. C. Read IGFBP mRNA expression in small intestine of rat during postnatal development Am J Physiol Gastrointest Liver Physiol, December 1, 2001; 281(6): G1378 - G1384. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dubaquie, D. L. Mortensen, A. Intintoli, D. A. Hogue, G. Nakamura, P. Rancatore, P. Lester, M. D. Sadick, E. Filvaroff, P. J. Fielder, et al. Binding Protein-3-Selective Insulin-Like Growth Factor I Variants: Engineering, Biodistributions, and Clearance Endocrinology, January 1, 2001; 142(1): 165 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Kritsch, D. J. Huss, and D. M. Ney Greater potency of IGF-I than IGF-I/BP-3 complex in catabolic parenterally fed rats Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E252 - E262. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Wallace, R. C. Cuneo, R. Baxter, H. Orskov, N. Keay, C. Pentecost, R. Dall, T. Rosen, J. O. Jorgensen, A. Cittadini, et al. Responses of the Growth Hormone (GH) and Insulin-Like Growth Factor Axis to Exercise, GH Administration, and GH Withdrawal in Trained Adult Males: A Potential Test for GH Abuse in Sport J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3591 - 3601. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Robertson, D. A. Belford, and F. J. Ballard Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E663 - E671. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |